Cannabiz have found out from the horse’s mouth..
The Therapeutic Goods Administration (TGA) delayed an announcement on the down-scheduling of CBD until late-December to consider further advice from a joint meeting of the Advisory Committees on Medicines and Chemicals Scheduling, Cannabiz has been told.
The TGA said public consultation on the interim decision to down-schedule low-dose CBD was open from September 9 to October 13 and no further consultation will take place.
Read their full report at
